{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T01:38:54Z","timestamp":1761183534054,"version":"build-2065373602"},"reference-count":19,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Pharmacokinetics"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.dmpk.2020.05.001","type":"journal-article","created":{"date-parts":[[2020,6,7]],"date-time":"2020-06-07T11:02:27Z","timestamp":1591527747000},"page":"397-400","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Molecular characterization of UDP-glucuronosyltransferases 3A and 8A in cynomolgus macaques"],"prefix":"10.1016","volume":"35","author":[{"given":"Yasuhiro","family":"Uno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1068-4261","authenticated-orcid":false,"given":"Hiroshi","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dmpk.2020.05.001_bib1","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1146\/annurev.pharmtox.40.1.581","article-title":"Human UDP-glucuronosyltransferases: metabolism, expression, and disease","volume":"40","author":"Tukey","year":"2000","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"1\u20132","key":"10.1016\/j.dmpk.2020.05.001_bib2","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0009-2797(00)00198-8","article-title":"Roles of glucuronidation and UDP-glucuronosyltransferases in xenobiotic bioactivation reactions","volume":"129","author":"Ritter","year":"2000","journal-title":"Chem Biol Interact"},{"issue":"10","key":"10.1016\/j.dmpk.2020.05.001_bib3","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/01.fpc.0000173483.13689.56","article-title":"Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily","volume":"15","author":"Mackenzie","year":"2005","journal-title":"Pharmacogenetics Genom"},{"issue":"3","key":"10.1016\/j.dmpk.2020.05.001_bib4","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1124\/mol.110.069336","article-title":"The novel UDP glycosyltransferase 3A2: cloning, catalytic properties, and tissue distribution","volume":"79","author":"MacKenzie","year":"2011","journal-title":"Mol Pharmacol"},{"issue":"52","key":"10.1016\/j.dmpk.2020.05.001_bib5","doi-asserted-by":"crossref","first-page":"36205","DOI":"10.1074\/jbc.M807961200","article-title":"Identification of UDP glycosyltransferase 3A1 as a UDP N-acetylglucosaminyltransferase","volume":"283","author":"Mackenzie","year":"2008","journal-title":"J\u00a0Biol Chem"},{"issue":"2","key":"10.1016\/j.dmpk.2020.05.001_bib6","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.pharmthera.2012.01.009","article-title":"The glycosidation of xenobiotics and endogenous compounds: versatility and redundancy in the UDP glycosyltransferase superfamily","volume":"134","author":"Meech","year":"2012","journal-title":"Pharmacol Therapeut"},{"key":"10.1016\/j.dmpk.2020.05.001_bib7","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1124\/mol.114.093823","article-title":"A\u00a0novel function for UDP glycosyltransferase 8: galactosidation of bile acids","volume":"87","author":"Meech","year":"2015","journal-title":"Mol Pharmacol"},{"issue":"3","key":"10.1016\/j.dmpk.2020.05.001_bib8","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3109\/03602532.2010.549492","article-title":"Macaque cytochromes P450: nomenclature, transcript, gene, genomic structure, and function","volume":"43","author":"Uno","year":"2011","journal-title":"Drug Metab Rev"},{"issue":"2","key":"10.1016\/j.dmpk.2020.05.001_bib9","doi-asserted-by":"crossref","first-page":"142","DOI":"10.2174\/138920010791110854","article-title":"Macaque CYP2C76 encodes cytochrome P450 enzyme not orthologous to any human isozymes","volume":"11","author":"Uno","year":"2010","journal-title":"Curr Drug Metabol"},{"issue":"2","key":"10.1016\/j.dmpk.2020.05.001_bib10","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1124\/mol.106.022673","article-title":"CYP2C76, a novel cytochrome P450 in cynomolgus monkey, is a major CYP2C in liver, metabolizing tolbutamide and testosterone","volume":"70","author":"Uno","year":"2006","journal-title":"Mol Pharmacol"},{"issue":"1","key":"10.1016\/j.dmpk.2020.05.001_bib11","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1080\/00498250600968275","article-title":"CYP2C76-mediated species difference in drug metabolism: a comparison of pitavastatin metabolism between monkeys and humans","volume":"37","author":"Uno","year":"2007","journal-title":"Xenobiotica"},{"issue":"1","key":"10.1016\/j.dmpk.2020.05.001_bib12","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1124\/dmd.114.061275","article-title":"Evaluation of 89 compounds for identification of substrates for cynomolgus monkey CYP2C76, a new bupropion\/nifedipine oxidase","volume":"43","author":"Hosaka","year":"2015","journal-title":"Drug Metab Dispos"},{"issue":"4","key":"10.1016\/j.dmpk.2020.05.001_bib13","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1742-7843.2011.00740.x","article-title":"Metabolism of P450 probe substrates by cynomolgus monkey CYP2C76 Basic","volume":"109","author":"Uno","year":"2011","journal-title":"Clin Pharmacol Toxicol"},{"issue":"3","key":"10.1016\/j.dmpk.2020.05.001_bib14","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.bcp.2010.11.003","article-title":"CYP1D1, pseudogenized in human, is expressed and encodes a functional drug-metabolizing enzyme in cynomolgus monkey","volume":"81","author":"Uno","year":"2011","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"10.1016\/j.dmpk.2020.05.001_bib15","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1124\/dmd.110.036574","article-title":"CYP2G2, pseudogenized in human, is expressed in nasal mucosa of cynomolgus monkey and encodes a functional drug-metabolizing enzyme","volume":"39","author":"Uno","year":"2011","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmpk.2020.05.001_bib16","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.bcp.2018.06.027","article-title":"Molecular and functional characterization of UDP-glucuronosyltransferase 1A in cynomolgus macaques","volume":"155","author":"Uno","year":"2018","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.dmpk.2020.05.001_bib17","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.bcp.2019.03.002","article-title":"Functional and molecular characterization of UDP-glucuronosyltransferase 2 family in cynomolgus macaques","volume":"163","author":"Uno","year":"2019","journal-title":"Biochem Pharmacol"},{"issue":"29","key":"10.1016\/j.dmpk.2020.05.001_bib18","doi-asserted-by":"crossref","first-page":"24122","DOI":"10.1074\/jbc.M112.343608","article-title":"Identification of residues that confer sugar selectivity to UDP-glycosyltransferase 3A (UGT3A) enzymes","volume":"287","author":"Meech","year":"2012","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.dmpk.2020.05.001_bib19","doi-asserted-by":"crossref","first-page":"113748","DOI":"10.1016\/j.bcp.2019.113748","article-title":"Molecular characterization of functional UDP-glucuronosyltransferases 1A and 2B in common marmosets","volume":"172","author":"Uno","year":"2020","journal-title":"Biochem Pharmacol"}],"container-title":["Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347436720303633?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347436720303633?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:55:11Z","timestamp":1761162911000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347436720303633"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S1347436720303633"],"URL":"https:\/\/doi.org\/10.1016\/j.dmpk.2020.05.001","relation":{},"ISSN":["1347-4367"],"issn-type":[{"type":"print","value":"1347-4367"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular characterization of UDP-glucuronosyltransferases 3A and 8A in cynomolgus macaques","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Pharmacokinetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dmpk.2020.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}